The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE study
Lotte van der Weijst*, David Azria, Patrick Berkovic, Pierre Boisselier, Erik Briers, Renée Bultijnck, Jenny Chang-Claude, Ananya Choudhury, Gilles Defraene, Sylvian Demontois, Rebecca M Elliott, Dawn Ennis, Corinne Faivre-Finn, Marzia Franceschini, Tommaso Giandini, Alexandra Giraldo, Sara Gutiérrez-Enríquez, Carsten Herskind, Daniel S Higginson, Sarah L KernsKerstie Johnson, Maarten Lambrecht, Philippe Lang, Mónica Ramos, Tiziana Rancati, Andreas Rimner, Barry S Rosenstein, Dirk De Ruysscher, Ahmed Salem, Claudia Sangalli, Petra Seibold, Paloma Sosa Fajardo, Elena Sperk, Hilary Stobart, Holly Summersgill, Veerle Surmont, Paul Symonds, Begoña Taboada-Valladares, Christopher J Talbot, Ana Vega, Liv Veldeman, Marlon R Veldwijk, Tim Ward, Adam Webb, Catharine M L West, Yolande Lievens, REQUITE consortium
Research output: Contribution to journal › Article › Academic › peer-review
Fingerprint
Dive into the research topics of 'The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE study'. Together they form a unique fingerprint.